The relation between life quality and subtype of the disease in patients with irritable bowel syndrome

The relation between life quality and subtype of the disease in patients with irritable bowel syndrome

Aim: Irritable bowel syndrome (IBS) is not a life-threatening condition; however, people with IBS have a low quality of life (QOL) thatmight affect their education, social and professional achievements. Many studies have shown that patients who have IBS havelower QOL compared to the general population together with patients who have chronic diseases. The relation between IBS subtypeand QOL is still not clear. For this reason, our study aims to evaluate the relationship between subtypes of the disease and QOL inpatients who have IBS.Material and Methods: The 100 patients with IBS and 100 healthy individuals who were aged from 18 to 65 years, were included inour study. The relationship between disease subtype and quality of life in IBS patients were analyzed.Results: Regarding quality of life between the groups in the examination; the overall health scores were lower at a significant levelin the patients who had IBS subtype as predominant-constipation than those who had IBS subtypes as predominant-diarrheaand mixed type (p=0.013;p=0.045;p

___

  • 1. Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clinical Epidemiol 2014;6:71-80.
  • 2. Chang FY, Lu CL, Chen TS. The current prevalence of irritable bowel syndrome in Asia. J Neu-rogastroenterol Motil 2010;16:389-400.
  • 3. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-80.
  • 4. El-Serag HB, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002;16:1171- 85.
  • 5. Nellesen D, Yee K, Chawla A, et al. A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation. J Managed Care Pharm 2013;19:755-64.
  • 6. Gralnek IM, Hays RD, Kilbourne AM, et al. Racial differences in the impact of irritable bowel syndrome on health-related quality of life. J Clin Gastroenterol 2004;38:782-9.
  • 7. Gralnek IM, Hays RD, Kilbourne A, et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000;119:654-60.
  • 8. Mönnikes H. Quality of life in patients with irritable bowel syndrome. J Clin Gastroenterol 2011;45:98-101
  • 9. Singh P, Agnihotri A, Pathak MK, et al. Psychiatric, somatic and other functional gastrointestinal disorders in patients with irritable bowel syndrome at a tertiary care center. J Neurogastroenterol Motil 2012;18:324-31.
  • 10. Sinharoy U, Sinharoy K, Mukhopadhyay P, et al. Pattern of irritable bowel syndrome and its impact on quality of life: A tertiary hospital based study from Kolkata on newly diagnosed pa-tients of irritable bowel syndrome attending general medical outpatient department. CHRISMED J Health and Res 2015;3:238-44.
  • 11. Singh P, Staller K, Barshop K, et al. Patients with irritable bowel syndrome-diarrhea have lower disease specific quality of life than irritable bowel syndrome-constipation. World J Gastroenter-ol 2015;21:8103-9.
  • 12. Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology 2016;5085:223-7.
  • 13. Tillisch K, Labus JS, Naliboff BD, et al. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome. Am J Gastroenterol 2005;100:896-904.
  • 14. Ware JE Jr, Sherbourne CD. The MOS 36-item shortform healthsurvey (SF-36). I. Conceptu-alframe workanditemselection. Med Care 1992;30:473-83.
  • 15. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622-9.
  • 16. Whitehead WE, Burnett CK, Cook III EW, Taub E. Impact of irritable bowel syndrome on quali-ty of life. Dig Dis Sci 1996;41:2248-53.
  • 17. Chassany O, Marquis P, Scherrer B, et al. Validation of a specific quality of life questionnaire for functional digestive disorders. Gut 1999;44:527-33.
  • 18. Strassels SA, Hahn BA. Short form 36 (SF-36) scores in patients with IBS compared with US norms. Gastroenterology 1997;112:44.
  • 19. Mearin F, Balboa A, Badía X, et al. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype. Eur J Gastroenterol Hepatol 2003;15:165-72.
  • 20. Jamali R, Jamali A, Poorrahnama M, et al. Evaluation of healthrelated quality of life in irritable bowel syndrome patients. Health Qual Life Outcomes 2012;10:12.
  • 21. Cho HS, Park JM, Lim CH, et al. Anxiety, depression and quality of life in patients with irritable bowel syndrome. Gut Liver 2011;5:29-36.
  • 22. Tillisch K, Labus JS, Naliboff BD, et al. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome. Am J Gastroenterol 2005;100:896-904.
  • 23. Schmulson M, Ortiz O, Mejia-Arangure JM, et al. Further validation of the IBS-QOL: female Mexican IBS patients have poorer quality of life than females from North Carolina. Dig Dis Sci 2007;52:2950-5.
  • 24. Si JM, Wang LJ, Chen SJ, et al. Irritable bowel syndrome consulters in Zhejiang province: the symptoms pattern, predominant bowel habit subgroups and quality of life. World J Gastroenterol 2004;10:1059-64.
Annals of Medical Research-Cover
  • Yayın Aralığı: Aylık
  • Yayıncı: İnönü Üniversitesi Tıp Fakültesi
Sayıdaki Diğer Makaleler

Does MPV / Plt ratios support the diagnosis in acute ischemic stroke patients?

Ayse SAHİN TUTAK

Evaluation of the presence of effusion in patients with temporomandibular joint disorder

Aydın KESKİNRÜZGAR, Hayri OGUL, Goksel Simsek KAYA, Gunay YAPİCİ YAVUZ

Incidental gallbladder carcinoma during or after cholecystectomy

Bora BARUT, Adil BAŞKIRAN

The association of GLUT-1, Galectin 3 and Claudin 1 staining with the type of renal tumors

Pelin YILDIZ, Ganime ÇOBAN, Nurcan UNVER, Seval TURNA, Cevper ERSÖZ, Nur BUYUKPİNARBASİLİ, Zuhal GÜCİN

Pre-, intra- and post-operative management in phacoemulsification surgery for completely monocular cases

Osman Melih CEYLAN, Turgut YILMAZ, Elif Betül TÜRKOĞLU, Seyhan DİKCİ, Emrah ÖZTÜRK, Soner DEMİREL, Harika Gözde GÖZÜKARA BAĞ, Penpe Gül FIRAT, Abuzer GUNDUZ

The relation between life quality and subtype of the disease in patients with irritable bowel syndrome

Ramazan DERTLİ, Yusuf KAYAR, Nurcan UNVER, Ismet KİRPİNAR, Mehmet AGİN

The evaluation of mean platelet volume in infants with atopic dermatitis

Mehmet Yaşar ÖZKARS, Hatice SANLİ GUNES, Sevcan IPEK

Parameters associated with survival in patients undergoing surgical treatment due to rectal cancer

Koray KARABULUT, Mehmet SARAC, Nidal İFLAZOĞLU, Serdar GURSUL

Chemotherapeutic effects of doxorubicin loaded PEG coated TiO? nanocarriers on breast cancer cell lines

Erkan GUMUS, Ayca TAS, Yavuz SİLİG, Neşe KEKLİKCİOĞLU ÇAKMAK, Mustafa ATABEY

Slient death

Bilgehan DEMİRKALE